院内感染(Nosocomial Infections)：世界の治験レビュー2014年下半期版...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Nosocomial Infections 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Nosocomial Infections to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Nosocomial Infections to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Nosocomial Infections 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Nosocomial Infections Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Pfizer Inc. 32
Clinical Trial Overview of Pfizer Inc. 32
AstraZeneca PLC 34
Clinical Trial Overview of AstraZeneca PLC 34
Merck & Co., Inc. 35
Clinical Trial Overview of Merck & Co., Inc. 35
Bayer AG 36
Clinical Trial Overview of Bayer AG 36
Tetraphase Pharmaceuticals Inc. 37
Clinical Trial Overview of Tetraphase Pharmaceuticals Inc. 37
Janssen Pharmaceuticals, Inc. 38
Clinical Trial Overview of Janssen Pharmaceuticals, Inc. 38
Johnson & Johnson 39
Clinical Trial Overview of Johnson & Johnson 39
Cubist Pharmaceuticals, Inc. 40
Clinical Trial Overview of Cubist Pharmaceuticals, Inc. 40
Janssen Research & Development, LLC 41
Clinical Trial Overview of Janssen Research & Development, LLC 41
Achaogen Inc. 42
Clinical Trial Overview of Achaogen Inc. 42
Clinical Trial Overview of Top Institutes / Government 43
University of Oxford 43
Clinical Trial Overview of University of Oxford 43
Mashhad University of Medical Sciences 44
Clinical Trial Overview of Mashhad University of Medical Sciences 44
Department of Health, UK 45
Clinical Trial Overview of Department of Health, UK 45
Medical University of Warsaw 46
Clinical Trial Overview of Medical University of Warsaw 46
Rigshospitalet 47
Clinical Trial Overview of Rigshospitalet 47
Hopitaux Universitaires de Geneve 48
Clinical Trial Overview of Hopitaux Universitaires de Geneve 48
University of Calgary 49
Clinical Trial Overview of University of Calgary 49
U.S. Department of Veterans Affairs 50
Clinical Trial Overview of U.S. Department of Veterans Affairs 50
Duke University 51
Clinical Trial Overview of Duke University 51
University of Cincinnati 52
Clinical Trial Overview of University of Cincinnati 52
Five Key Clinical Profiles 53
Appendix 101
Abbreviations 101
Definitions 101
Research Methodology 102
Secondary Research 102
About GlobalData 103
Contact Us 103
Disclaimer 103
Source 103